Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02018549
What this trial is testing

An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI

Who this might be right for
COPD
Chiesi Farmaceutici S.p.A. 72
Early research (Phase 1)Study completedNCT00983255
What this trial is testing

Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)

Who this might be right for
Bacterial Infections
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 90
Large-scale testing (Phase 3)WithdrawnNCT01941004
What this trial is testing

Safety and Efficacy of Fingolimod in MS Patients in China

Who this might be right for
Multiple Sclerosis (Relapsing Remitting)
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT06042478
What this trial is testing

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 470
Not applicableStudy completedNCT06931158
What this trial is testing

HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic Pain

Who this might be right for
Chronic Low-back PainChronic Pain
Rhode Island Hospital 327
Testing effectiveness (Phase 2)Ended earlyNCT02065336
What this trial is testing

Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Arrowhead Pharmaceuticals 58
Large-scale testing (Phase 3)Active Not RecruitingNCT04057898
What this trial is testing

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
MediciNova 234
Large-scale testing (Phase 3)Study completedNCT02954887
What this trial is testing

Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

Who this might be right for
Infantile Spasms
Jazz Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT01515007
What this trial is testing

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

Who this might be right for
Non Cystic Fibrosis Bronchiectasis
Aradigm Corporation 278
Post-approval studies (Phase 4)Study completedNCT00147628
What this trial is testing

Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire

Who this might be right for
Impotence
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 209
Large-scale testing (Phase 3)Looking for participantsNCT07435428
What this trial is testing

Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

Who this might be right for
Moderate to Severe Glabellar Lines
Ipsen 1,300
Large-scale testing (Phase 3)Study completedNCT01697592
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 585
Early research (Phase 1)WithdrawnNCT05033912
What this trial is testing

CST-2032 in Subjects With Cognitive Impairment

Who this might be right for
Mild Cognitive Impairment (MCI)Parkinson Disease (PD)
CuraSen Therapeutics, Inc.
Early research (Phase 1)Study completedNCT03516630
What this trial is testing

Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers

Who this might be right for
Healthy
Aziende Chimiche Riunite Angelini Francesco S.p.A 20
Large-scale testing (Phase 3)Study completedNCT01261611
What this trial is testing

Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia

Who this might be right for
Cervical Dystonia
Ipsen 382
Large-scale testing (Phase 3)Not Yet RecruitingNCT06606093
What this trial is testing

Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients

Who this might be right for
Type 2 Diabetic Nephropathy
Daewoong Pharmaceutical Co. LTD. 348
Large-scale testing (Phase 3)Study completedNCT03920540
What this trial is testing

GC1111 in Hunter Syndrom Patients

Who this might be right for
Hunter Syndrome
Green Cross Corporation 32
Early research (Phase 1)Study completedNCT02283788
What this trial is testing

Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization

Who this might be right for
Epilepsy
Bial - Portela C S.A. 67
Large-scale testing (Phase 3)Study completedNCT00365586
What this trial is testing

Ketoprofen Topical Patch, 20% in the Treatment of Pain Associated With Osteoarthritis Flare of the Knee

Who this might be right for
Osteoarthritis
APR Applied Pharma Research s.a. 300
Post-approval studies (Phase 4)Study completedNCT01841125
What this trial is testing

Escitalopram for the Treatment of Depression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Konkuk University Medical Center 84
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation